Category - M&As and partnerships

PierianDx and Pillar Biosciences Announce Partnership to Support Precision Cancer Care

10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions

Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Tempus and LabCorp Announce Collaboration to Accelerate Clinical Trial Patient Participation

Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria

Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics

Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement

Syapse and FDA Expand Existing Research Collaboration to Rapidly Generate Real-World Data Related to COVID-19 and Cancer

Blackstone to Acquire Ancestry®, Leading Online Family History Business, for $4.7 Billion

Genuity Science Announces Strategic Collaboration with Nashville Biosciences

Illumina Acquires Enancio’s Compression Software

Bluebee’s coherent data strategy set to unify Illumina’s data analytics products

Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology

Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale

Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care

Copyright © 2026. enlighenbio LLC. All rights reserved.